KCNAB2
Basic information
Region (hg38): 1:5990927-6101193
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KCNAB2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 21 | ||||
missense | 24 | 30 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 7 | 2 | 9 | |||
non coding | 14 | |||||
Total | 0 | 0 | 31 | 25 | 10 |
Variants in KCNAB2
This is a list of pathogenic ClinVar variants found in the KCNAB2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-5992257-C-A | Nephronophthisis 4 • Senior-Loken syndrome 4 | Uncertain significance (Jan 12, 2018) | ||
1-5992295-T-A | Nephronophthisis 4 • Senior-Loken syndrome 4 | Conflicting classifications of pathogenicity (Jan 12, 2018) | ||
1-5992407-G-A | Nephronophthisis 4 • Senior-Loken syndrome 4 | Uncertain significance (Jan 13, 2018) | ||
1-5992411-G-T | Nephronophthisis 4 • Senior-Loken syndrome 4 | Uncertain significance (Jan 12, 2018) | ||
1-5992430-C-T | Nephronophthisis • Renal dysplasia and retinal aplasia | Uncertain significance (Jun 14, 2016) | ||
1-5992440-C-T | Nephronophthisis • Renal dysplasia and retinal aplasia | Uncertain significance (Jun 14, 2016) | ||
1-5992441-G-A | Renal dysplasia and retinal aplasia • Nephronophthisis | Uncertain significance (Jun 14, 2016) | ||
1-5992442-C-G | Nephronophthisis • Renal dysplasia and retinal aplasia | Uncertain significance (Jun 14, 2016) | ||
1-5992511-G-A | Benign (May 16, 2021) | |||
1-5992521-G-A | Benign (May 13, 2021) | |||
1-6040585-C-T | Likely benign (Nov 01, 2022) | |||
1-6040588-C-T | not specified | Uncertain significance (Feb 22, 2023) | ||
1-6040589-G-A | Likely benign (Feb 01, 2024) | |||
1-6040609-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
1-6041858-G-A | Likely benign (Jun 14, 2018) | |||
1-6051550-C-T | KCNAB2-related disorder | Likely benign (Jun 08, 2020) | ||
1-6051557-C-G | not specified | Uncertain significance (Apr 13, 2022) | ||
1-6051558-G-A | not specified | Uncertain significance (Oct 06, 2022) | ||
1-6051567-C-T | not specified | Uncertain significance (Aug 12, 2022) | ||
1-6051568-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
1-6051573-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
1-6051595-A-G | not specified | Uncertain significance (Jul 26, 2022) | ||
1-6051615-C-T | not specified | Uncertain significance (Jan 24, 2024) | ||
1-6051641-G-C | KCNAB2-related disorder | Benign (Aug 28, 2019) | ||
1-6051648-C-T | not specified | Uncertain significance (Dec 21, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KCNAB2 | protein_coding | protein_coding | ENST00000378083 | 15 | 109728 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.800 | 0.200 | 125740 | 0 | 8 | 125748 | 0.0000318 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.60 | 145 | 264 | 0.550 | 0.0000169 | 2684 |
Missense in Polyphen | 23 | 72.748 | 0.31616 | 732 | ||
Synonymous | 0.437 | 106 | 112 | 0.947 | 0.00000789 | 806 |
Loss of Function | 3.96 | 5 | 27.3 | 0.183 | 0.00000125 | 305 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000929 | 0.0000924 |
European (Non-Finnish) | 0.0000267 | 0.0000264 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cytoplasmic potassium channel subunit that modulates the characteristics of the channel-forming alpha-subunits (PubMed:7649300, PubMed:11825900). Contributes to the regulation of nerve signaling, and prevents neuronal hyperexcitability (By similarity). Promotes expression of the pore-forming alpha subunits at the cell membrane, and thereby increases channel activity (By similarity). Promotes potassium channel closure via a mechanism that does not involve physical obstruction of the channel pore (PubMed:7649300, PubMed:11825900). Promotes KCNA4 channel closure (PubMed:7649300, PubMed:11825900). Modulates the functional properties of KCNA5 (By similarity). Enhances KCNB2 channel activity (By similarity). Binds NADPH and has NADPH- dependent aldoketoreductase activity (By similarity). Has broad substrate specificity and can catalyze the reduction of methylglyoxal, 9,10-phenanthrenequinone, prostaglandin J2, 4- nitrobenzaldehyde, 4-nitroacetophenone and 4-oxo-trans-2-nonenal (in vitro) (By similarity). {ECO:0000250|UniProtKB:P62482, ECO:0000250|UniProtKB:P62483, ECO:0000269|PubMed:11825900, ECO:0000269|PubMed:7649300}.;
- Pathway
- Antiarrhythmic Pathway, Pharmacodynamics;Metapathway biotransformation Phase I and II;Neutrophil degranulation;Innate Immune System;Immune System;Neuronal System;Voltage gated Potassium channels;Potassium Channels
(Consensus)
Recessive Scores
- pRec
- 0.186
Intolerance Scores
- loftool
- 0.498
- rvis_EVS
- -0.43
- rvis_percentile_EVS
- 25.37
Haploinsufficiency Scores
- pHI
- 0.359
- hipred
- Y
- hipred_score
- 0.806
- ghis
- 0.537
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.904
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Kcnab2
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- kcnab2b
- Affected structure
- Mauthner neuron
- Phenotype tag
- abnormal
- Phenotype quality
- process quality
Gene ontology
- Biological process
- hematopoietic progenitor cell differentiation;neutrophil degranulation;neuromuscular process;oxidation-reduction process;NADPH oxidation;potassium ion transmembrane transport;regulation of potassium ion transmembrane transport;regulation of protein localization to cell surface
- Cellular component
- cytosol;microtubule;plasma membrane;voltage-gated potassium channel complex;postsynaptic density;membrane;cell junction;extrinsic component of cytoplasmic side of plasma membrane;specific granule membrane;axon terminus;juxtaparanode region of axon;tertiary granule membrane;pinceau fiber
- Molecular function
- aldo-keto reductase (NADP) activity;voltage-gated potassium channel activity;potassium channel regulator activity